Disrupting β-Amyloid Aggregation for Alzheimer Disease Treatment
Journal:
Current Topics in Medicinal Chemistry
Volume:
7
Page:
115-126
Author(s):
L. D. Estrada and C. Soto
Glial Reaction in Parkinsons Diseases: Inflammatory Activation Signaling of Glia as a Potential Therapeutic Target
Journal:
Current Signal Transduction Therapy
Volume:
2
Page:
77-90
Author(s):
Dong-Kug Choi and Kyoungho Suk
Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation
Journal:
Recent Patents on CNS Drug Discovery (Discontinued)
Volume:
2
Page:
37-46
Author(s):
Rodrigo R. Resende, Henning Ulrich and Marcella Faria
Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System Diseases
Journal:
Recent Patents on CNS Drug Discovery (Discontinued)
Volume:
2
Page:
57-78
Author(s):
Istvan Tarnawa, Hedvig Bolcskei and Pal Kocsis
Patent Annotations
Journal:
Recent Patents on CNS Drug Discovery (Discontinued)
Volume:
2
Page:
85-89
Author(s):
Bentham Science Publisher
Subject Index To Volume 1
Journal:
Recent Patents on CNS Drug Discovery (Discontinued)
Volume:
2
Page:
vi-vi
Author(s):
Bentham Science Publisher
An Overview of Parkinsons Disease and the Cannabinoid System and Possible Benefits of Cannabinoid-Based Treatments
Journal:
Current Medicinal Chemistry
Volume:
13
Page:
3705-3718
Author(s):
Isabel Lastres-Becker and Javier Fernandez-Ruiz
Induced Adaptive Resistance to Nitrooxidative Stress in the CNS: Therapeutic Implications
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
6
Page:
281-291
Author(s):
Amy Bishop, Renea Gooch and James Anderson
The Function of the Selective Inhibitors of Cycloxygenase 2
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
6
Page:
1375-1381
Author(s):
Yepeng Luan and Wenfang Xu
A Role for TGF-β Signaling in Neurodegeneration: Evidence from Genetically Engineered Models
Journal:
Current Alzheimer Research
Volume:
3
Page:
505-513
Author(s):
Ina Tesseur and Tony Wyss-Coray